Literature DB >> 11444907

IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact.

F Jungo1, J M Dayer, C Modoux, N Hyka, D Burger.   

Abstract

Tumour necrosis factor (TNF)-alpha and interleukin (IL-)1beta, essential players in the pathogenesis of immuno-inflammatory diseases, are strongly induced in monocytes by direct contact with stimulated T lymphocytes. The present study shows that the latter mechanism is inhibited by interferon (IFN)-beta. In co-cultures of autologous T lymphocytes and monocytes stimulated by phytohaemagglutinin (PHA), IFN-beta inhibited the production of TNF-alpha and IL-1beta by 88 and 98%, respectively, whereas the simultaneous production of IL-1 receptor antagonist (IL-1Ra), was enhanced two-fold. The latter effects of IFN-beta were independent of modulations in IFN-gamma, IL-4 and IL-10 production. When monocytes were activated by plasma membranes of stimulated T cells, IFN-beta slightly inhibited the production of TNF-alpha and IL-1beta, while enhancing 1.5-fold that of IL-1Ra. The latter effect correlated with the persistence of high steady-state levels of IL-1Ra mRNA after 24 h of activation. Membranes isolated from T lymphocytes that had been stimulated in the presence of IFN-beta displayed a 80% decrease in their capacity to induce the production of IL-1beta and TNF-alpha in monocytes, whereas IL-1Ra induction was decreased by only 32%. These results demonstrate that IFN-beta modulates contact-mediated activation of monocytes by acting on both T lymphocytes and monocytes, decreasing the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes and directly enhancing the production of IL-1Ra in the latter cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444907     DOI: 10.1006/cyto.2001.0884

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  21 in total

1.  Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes.

Authors:  Rakel Carpintero; Karim J Brandt; Lyssia Gruaz; Nicolas Molnarfi; Patrice H Lalive; Danielle Burger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes.

Authors:  Lyssia Gruaz; Céline Delucinge-Vivier; Patrick Descombes; Jean-Michel Dayer; Danielle Burger
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 3.  Post-transcriptional control of the interferon system.

Authors:  Khalid S A Khabar; Howard A Young
Journal:  Biochimie       Date:  2007-02-24       Impact factor: 4.079

Review 4.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

5.  Role of sphingosine kinase and sphingosine-1-phosphate in inflammatory arthritis.

Authors:  Wen-Qi Lai; Alirio J Melendez; Bernard P Leung
Journal:  World J Biol Chem       Date:  2010-11-26

6.  Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.

Authors:  Lauren M Smith; Lisa E Hensley; Thomas W Geisbert; Joshua Johnson; Andrea Stossel; Anna Honko; Judy Y Yen; Joan Geisbert; Jason Paragas; Elizabeth Fritz; Gene Olinger; Howard A Young; Kathleen H Rubins; Christopher L Karp
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

7.  Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.

Authors:  Kaushal S Gandhi; Fiona C McKay; Eve Diefenbach; Ben Crossett; Stephen D Schibeci; Robert N Heard; Graeme J Stewart; David R Booth; Jonathan W Arthur
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

8.  HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production.

Authors:  Rakel Carpintero; Lyssia Gruaz; Karim J Brandt; Anna Scanu; Dorothée Faille; Valery Combes; Georges E Grau; Danielle Burger
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

Review 9.  Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance.

Authors:  Tineke Cantaert; Dominique Baeten; Paul P Tak; Lisa G M van Baarsen
Journal:  Arthritis Res Ther       Date:  2010-10-28       Impact factor: 5.156

Review 10.  Inflammation in central nervous system injury.

Authors:  Stuart M Allan; Nancy J Rothwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-10-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.